Fluo Labs: The Future of Allergy Relief (212)

Episode 12 May 14, 2022 00:25:00
Fluo Labs: The Future of Allergy Relief (212)
Innovation4Alpha
Fluo Labs: The Future of Allergy Relief (212)

May 14 2022 | 00:25:00

/

Show Notes

Fluo Labs, Inc. is a premarket clinical stage medical device company pursuing innovative technology to provide drug-free relief of nasal allergy (i.e. hay fever) symptoms. They are inventing a whole new way for sufferers of seasonal allergies to get symptom relief, and ultimately improve their quality of life. The Fluo device is designed to use light therapy to reduce inflammation and temporarily alleviate allergy symptoms as a completely drug-free alternative to common allergy medications.

Other Episodes

Episode 4

August 23, 2023 00:25:13
Episode Cover

Torque3: Advancing Stroke Rehabilitation w/ VR

Torque3 is developing a neurorehabilitation solution that has shown in early testing to result in significantly better recovery outcomes.  A wealth of research over...

Listen

Episode 9

July 09, 2021 00:12:49
Episode Cover

Startup Profile: Happyr Health (009)

Chronic pain affects the mental health of young people and it requires continuous and complex self-management that often fails. Happyr Health supports teens with...

Listen

Episode 21

September 26, 2021 00:33:34
Episode Cover

Matt Patsky, CEO of Trillium Asset Management (021)

Matt Patsky is CEO and Lead Portfolio Manager of the Trillium ESG Global Equity strategy and Portfolio Manager of the Trillium Sustainable Opportunities strategy....

Listen